Novartis-Myricx Bio Acquisition: $1.5B NMTi ADC Payload Deal
Analysis of Novartis's 2026 up to $1.5B acquisition of Myricx Bio, covering the NMTi ADC payload platform, B7-H3/HER2/TROP2 pipeline, deal terms, leadership, and biopharma M&A context.
Back to Articles
Articles tagged with “b7-h3-her2-pipeline”